TAG1 And NRG Pallas Sign Agreement On Next-Generation Cancer Therapies
Aim is to deliver significant quantities of Pb-212 to drug innovators across Europe
Lead-212
UK To Produce Cutting Edge Cancer Treatments Using Reprocessed Uranium From Spent Nuclear Fuel
Landmark agreement announced with Cambridge biotech firm founded by Nobel Prize winner
UK Invests £18.8 Million In Project To Recycle Spent Nuclear Fuel For Precision Cancer Medicines
Aim is to use lead-212 to create treatments called targeted alpha therapies
NRG Pallas Signs Expanded Radium-224 Supply Agreement With TAG1
Partnership will help address growing demand for isotopes and support development of cancer therapies
UK Announces Funding To Help Turn Nuclear ‘Waste’ Into Breakthrough Cancer Treatments
Radioisotope lead-212 can be extracted from reprocessed uranium
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options
© 2026 NucNet. All Rights Reserved.